Skip to main content
. 2022 Jan 10;22(Suppl 2):1061. doi: 10.1186/s12891-021-04953-8

Table 2.

Clinical scores

Subcategories Preoperative Follow-up at 10–16 years Δ (points)
HOOS total score (0–100) 32.25% (σ = 14.07) 91.91% (σ = 9.13) 59.66
S (Symptoms & Stiffness) 32.94% (σ = 15.69) 89.68% (σ = 12.14) 56.74
P (Pain) 33.25% (σ = 18.80) 94.37% (σ = 7.28) 61.12
A (Function, daily living) 33.29% (σ = 14.45) 80.16% (σ = 8.19) 46.87
SP (Function, sports and recreational activities) 22.04% (σ = 17.95) 85.17% (σ = 13.65) 62.77
Q (Quality of life) 19.94% (σ = 16.51) 74.42% (σ = 19.03) 54.48
SF12 PCS score 36.08% (σ = 9.14) 54.15% (σ = 8.52) 18.07
SF12 MCS score 28.57% (σ = 9.93) 47.09% (σ = 5.96) 18.52

Clinical outcome of patients treated with the Nanos total hip implant, assessed through Hip disability and Osteoarthritis Outcome Score (HOOS) and Short Form Survey (SF-12) Abbreviations: HOOS Hip Disability and Osteoarthritis Outcome, SF12 Short Form Survey, PCS Physical score, MCS Mental score, standard deviation